You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

  • Technology appraisal guidance
  • Reference number: TA210
  • Published:  15 December 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix B proposal paper presented to the Institute's Guidance Executive

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix B proposal paper presented to the Institute's Guidance Executive TA210 Vascular disease - clopidogrel and dipyridamole: Appendix B proposal paper presented to the Institute's Guidance Executive
29 July 2013
(662.08 Kb 12 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 26 July 2013

Back to top